Dr. Patrick Senam Kofi Fatsi is a dedicated interdisciplinary life scientist with expertise in molecular biology (including molecular genetics, evolutionary and population genetics, and translational science), epigenomics, microbiology (focusing on nanobacteria, biomineralization, and microbial taxonomy), pathology and immunology (particularly in host-pathogen relationships), antimicrobial resistance (AMR), public and global health, bioinformatics, and biotherapy and biopharmaceutics (such as immunomodulation, phototherapy, phytotherapy, and bacteriophage therapy). He is also skilled in animal handling and care, and microscopy and imaging.
Dr. Fatsi’s current research interests center on antimicrobial resistance, vaccinology, and immunomodulation. He explores the use of bioactive molecules from pathogens—both intracellular and extracellular—to combat antibiotic-resistant bacteria through immunomodulation techniques. His work aims to develop biotherapy-based technologies that could eventually reduce the reliance on chemotherapeutic antimicrobial agents in food-animal production, promoting environmental sustainability and consumer welfare.
His work ethic is characterized by a strong commitment to teamwork and transdisciplinary scientific collaboration, cultural versatility, and a readiness to embrace new challenges.
Dr. Patrick Senam Kofi Fatsi is a dedicated interdisciplinary life scientist with expertise in molecular biology (including molecular genetics, evolutionary and population genetics, and translational science), epigenomics, microbiology (focusing on nanobacteria, biomineralization, and microbial taxonomy), pathology and immunology (particularly in host-pathogen relationships), antimicrobial resistance (AMR), public and global health, bioinformatics, and biotherapy and biopharmaceutics (such as immunomodulation, phototherapy, phytotherapy, and bacteriophage therapy). He is also skilled in animal handling and care, and microscopy and imaging.
Dr. Fatsi’s current research interests center on antimicrobial resistance, vaccinology, and immunomodulation. He explores the use of bioactive molecules from pathogens—both intracellular and extracellular—to combat antibiotic-resistant bacteria through immunomodulation techniques. His work aims to develop biotherapy-based technologies that could eventually reduce the reliance on chemotherapeutic antimicrobial agents in food-animal production, promoting environmental sustainability and consumer welfare.
His work ethic is characterized by a strong commitment to teamwork and transdisciplinary scientific collaboration, cultural versatility, and a readiness to embrace new challenges.